Research peptide encyclopedia
Neutral, in-vitro / preclinical profiles of research peptides, plus a live scientific search across the PubMed literature. For laboratory research only.
Research axes
Explore research peptides by area to find compounds relevant to your field of study.
Metabolic
Peptides studied in research on metabolism, lipid oxidation and appetite regulation.
Growth hormone
Compounds studied on GH secretion, IGF-1 pathways and anabolic signalling.
Tissue repair
Peptides studied on the repair of tissues, tendons, ligaments and wound healing.
Cognition & focus
Compounds studied on cognition, neuroprotection and synaptic plasticity.
Longevity & anti-ageing
Peptides studied on cellular senescence, telomeres and markers of ageing.
Skin & hair
Peptides studied on skin, collagen, hair and cutaneous anti-ageing.
Hormonal balance
Peptides studied on hormonal balance and the reproductive axis.
Immunity
Peptides studied on immune modulation and the body's defences.
Scientific search engine
Live results from PubMed (NCBI). Research literature only — no medical advice.
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction.
Nauck MA, et al. · Cardiovascular diabetology · 2022
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.
Rosenstock J, et al. · Lancet (London, England) · 2021
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
Willard FS, et al. · JCI insight · 2020
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists.
Liu QK · Frontiers in endocrinology · 2024
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
Karagiannis T, et al. · Diabetologia · 2022
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity.
Drucker DJ · Diabetes care · 2024
How May GIP Enhance the Therapeutic Efficacy of GLP-1?
Samms RJ, et al. · Trends in endocrinology and metabolism: TEM · 2020
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
Coskun T, et al. · Molecular metabolism · 2018
GLP-1-based medications: Mechanisms involved in obesity treatment.
Salvador J · Medicina clinica · 2025
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.
Thomas MK, et al. · The Journal of clinical endocrinology and metabolism · 2021
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials.
Min T, et al. · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
Jalleh RJ, et al. · The Journal of clinical endocrinology and metabolism · 2024
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis.
Singh A, et al. · World journal of gastroenterology · 2024
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
Nauck MA, et al. · Diabetes, obesity & metabolism · 2021
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity.
Son JW, et al. · Endocrine reviews · 2026
Peptide profiles
BPC-157
A pentadecapeptide studied in preclinical tissue-repair research.
Read
TB-500
A synthetic fragment related to Thymosin Beta-4, studied in cell-migration research.
Read
GHK-Cu
A copper tripeptide (Gly-His-Lys) studied in in-vitro dermatological research.
Read
AHK-Cu
A copper tripeptide (Ala-His-Lys) studied in vitro on the hair follicle.
Read
Reta-R3
A multi-receptor research compound studied in a metabolic context.
Read
Ipamorelin
A peptide studied in vitro as a selective ghrelin-receptor agonist.
Read
CJC-1295 no DAC
A GHRH analogue studied in vitro for the growth-hormone pathway.
Read
PT-141
A peptide studied in vitro as a melanocortin-receptor agonist.
Read
Selank
A synthetic tuftsin analogue studied in vitro as a nootropic peptide.
Read
Tirzepatide
A research peptide studied in vitro as a dual GLP-1 / GIP agonist.
Read
Semaglutide
A research peptide studied in vitro as a GLP-1 receptor agonist.
ReadPeptide directory
A broad index of research peptides — class-level descriptors, each linking to the PubMed literature. Research use only.
| Peptide | Category | Structure | Research application | PubMed |
|---|---|---|---|---|
| BPC-157 | Tissue repair | Pentadecapeptide (15 aa) | Studied in preclinical / in-vitro research on tissue repair. | View |
| TB-500 | Tissue repair | Thymosin β4 fragment | Studied in preclinical / in-vitro research on cell migration. | View |
| GHK-Cu | Skin & hair | Copper tripeptide (Gly-His-Lys) | Studied in preclinical / in-vitro research on the extracellular matrix. | View |
| AHK-Cu | Skin & hair | Copper tripeptide (Ala-His-Lys) | Studied in preclinical / in-vitro research on the hair follicle. | View |
| Reta-R3 | Metabolic | Triple-receptor agonist (investigational) | Studied in preclinical / in-vitro research on metabolism. | View |
| Semaglutide | Metabolic | GLP-1 receptor agonist | Studied in preclinical / in-vitro research on metabolism. | View |
| Tirzepatide | Metabolic | Dual GIP/GLP-1 agonist | Studied in preclinical / in-vitro research on metabolism. | View |
| Cagrilintide | Metabolic | Amylin analogue | Studied in preclinical / in-vitro research on metabolism. | View |
| Survodutide | Metabolic | Dual GLP-1/glucagon agonist (investigational) | Studied in preclinical / in-vitro research on metabolism. | View |
| AOD-9604 | Metabolic | hGH fragment (176-191) | Studied in preclinical / in-vitro research on lipid metabolism. | View |
| MOTS-c | Metabolic | Mitochondrial-derived peptide | Studied in preclinical / in-vitro research on energy metabolism. | View |
| CJC-1295 | Growth hormone | GHRH analogue | Studied in preclinical / in-vitro research on GH secretion. | View |
| Ipamorelin | Growth hormone | Pentapeptide (ghrelin agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| GHRP-2 | Growth hormone | GH-releasing hexapeptide | Studied in preclinical / in-vitro research on GH secretion. | View |
| GHRP-6 | Growth hormone | GH-releasing hexapeptide | Studied in preclinical / in-vitro research on GH secretion. | View |
| Sermorelin | Growth hormone | GHRH analogue (1-29) | Studied in preclinical / in-vitro research on GH secretion. | View |
| Tesamorelin | Growth hormone | GHRH analogue | Studied in preclinical / in-vitro research on metabolism and GH. | View |
| Hexarelin | Growth hormone | Hexapeptide (ghrelin agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| IGF-1 LR3 | Growth hormone | Long-acting IGF-1 analogue | Studied in preclinical / in-vitro research on anabolic signalling (in vitro). | View |
| MK-677 (Ibutamoren) | Growth hormone | GH secretagogue (GHS-R agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| Semax | Cognition & focus | Synthetic heptapeptide (ACTH-derived) | Studied in preclinical / in-vitro research on neuroprotection. | View |
| Selank | Cognition & focus | Synthetic heptapeptide (tuftsin-derived) | Studied in preclinical / in-vitro research on anxiolytic effects. | View |
| Cerebrolysin | Cognition & focus | Neurotrophic peptide mixture | Studied in preclinical / in-vitro research on neuroprotection. | View |
| Dihexa | Cognition & focus | Hexapeptide (angiotensin IV-derived) | Studied in preclinical / in-vitro research on synaptogenesis. | View |
| P-21 (P021) | Cognition & focus | CNTF-derived peptide | Studied in preclinical / in-vitro research on neurogenesis. | View |
| Epithalon | Longevity & anti-ageing | Tetrapeptide (Ala-Glu-Asp-Gly) | Studied in preclinical / in-vitro research on telomeres and ageing. | View |
| FOXO4-DRI | Longevity & anti-ageing | FOXO4-p53 interaction inhibitor peptide | Studied in preclinical / in-vitro research on cellular senescence. | View |
| Humanin | Longevity & anti-ageing | Mitochondrial-derived peptide | Studied in preclinical / in-vitro research on cytoprotection. | View |
| Thymalin | Immunity | Thymic peptide | Studied in preclinical / in-vitro research on immune modulation. | View |
| Thymosin Alpha-1 | Immunity | Thymic peptide (28 aa) | Studied in preclinical / in-vitro research on immune modulation. | View |
| LL-37 | Immunity | Antimicrobial peptide (cathelicidin) | Studied in preclinical / in-vitro research on innate immunity. | View |
| KPV | Immunity | Tripeptide (Lys-Pro-Val) | Studied in preclinical / in-vitro research on inflammation (in vitro). | View |
| ARA-290 (Cibinetide) | Tissue repair | EPO-derived peptide (11 aa) | Studied in preclinical / in-vitro research on anti-inflammation and neuroprotection. | View |
| PT-141 (Bremelanotide) | Hormonal balance | Cyclic melanocortin peptide | Studied in preclinical / in-vitro research on melanocortin receptors. | View |
| Kisspeptin-10 | Hormonal balance | Regulatory decapeptide | Studied in preclinical / in-vitro research on the reproductive axis. | View |
| Oxytocin | Hormonal balance | Nonapeptide (neurohormone) | Studied in preclinical / in-vitro research on social behaviour. | View |
| Melanotan II | Skin & hair | α-MSH analogue heptapeptide | Studied in preclinical / in-vitro research on melanocortin receptors. | View |
| SNAP-8 | Skin & hair | Octapeptide (acetyl octapeptide-3) | Studied in preclinical / in-vitro research on the appearance of wrinkles (in vitro). | View |
| PAL-GHK | Skin & hair | Palmitoylated tripeptide | Studied in preclinical / in-vitro research on collagen (in vitro). | View |
39 / 39 peptides · links to PubMed literature.
Research peptides — Research Use Only
- Not for human consumption
- Not for the diagnosis, treatment or prevention of any disease